Adalimumab in budesonide and methotrexate refractory collagenous colitis

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 1, 2012, Pages 59-63

  Münch, Andreas ^a   Ignatova, Simone ^a   Ström, Magnus ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Adalimumab; Collagenous colitis; Microscopic colitis; Tumor necrosis factor antagonist

Indexed keywords

ADALIMUMAB; BUDESONIDE; COLESTYRAMINE; LOPERAMIDE; MESALAZINE; METHOTREXATE; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; COLLAGENOUS COLITIS; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; FECES ANALYSIS; FEMALE; HISTOLOGY; HUMAN; INTESTINE BIOPSY; INTESTINE MOTILITY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; REMISSION; SIGMOIDOSCOPY; VOMITING;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; BIOPSY; BUDESONIDE; COLITIS, COLLAGENOUS; DEFECATION; DRUG RESISTANCE; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; QUALITY OF LIFE; SIGMOIDOSCOPY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84055184713     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.639079     Document Type: Article

References (16)

1. Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C. Microscopic colitis: a common diarrhoeal disease. An epidemiologic study in Örebro, Sweden, 1993-1998. Gut 2004;53: 346-50. (Pubitemid 38241327)
2. Wickbom A NN, Eriksson S, Bohr J, Tysk C. Stable incidences of collagenous colitis and lymphocytic colitis in Örebro, Sweden, 1999-2008. Gut 2009;58.
3. Pardi DS, Loftus EV Jr., Smyrk TC, Kammer PP, Tremaine WJ, Schleck CD, et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 2007;56:504-8. (Pubitemid 46580505)
4. Warren BF, Edwards CM, Travis SP. Microscopic colitis: classification and terminology. Histopathology 2002;40: 374-6.
5. Madisch A, Heymer P, Voss C, Wigginghaus B, Bastlein E, Bayerdörffer E, et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis 2005;20:312-16. (Pubitemid 40909227)
6. Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 2009;104:235-41.
7. Miehlke S, Madisch A, Voss C, Morgner A, Heymer P, Kuhlisch E, et al. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther 2005;22:1115-19. (Pubitemid 41779519)
8. Bonderup OK, Hansen JB, Teglbjaerg PS, Christensen LA, Fallingborg JF. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebocontrolled trial. Gut 2009;58:68-72.
9. Pardi DS, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology 2001;120: 1483-4. (Pubitemid 32322323)
10. Riddell J, Hillman L, Chiragakis L, Clarke A. Collagenous colitis: oral low-dose methotrexate for patients with difficult symptoms: long-term outcomes. J Gastroenterol Hepatol 2007;22:1589-93. (Pubitemid 47383347)
11. Dupuy HJ. The Psychological General Well-Being (PGWBI) Index. In Wenger NK, Mattson ME, Furberg CF, Elinson J, editors. Assessment of quality of life in clinical trials of cardiovascular therapies. Washington, DC, USA: Le Jacq Publishing, Inc; 1984. pp 170-83.
12. Hjortswang H, Jarnerot G, Curman B, Sandberg-Gertzen H,Tysk C, Blomberg B, et al. The Short Health Scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol 2006;41:1196-203. (Pubitemid 44451683)
13. Hjortswang H, Tysk C, Bohr J, Benoni C, Kilander A, Larsson L, et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis 2009;15:1875-81.
14. Miehlke S, Madisch A, Bethke B, Morgner A, Kuhlisch E, Henker C, et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebocontrolled trial. Gastroenterology 2008;135:1510-16.
15. Tagkalidis P, Gibson PR, Bhathal PS. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol 2007;60:382-7. (Pubitemid 46596556)
16. Munch A, Söderholm JD, Ost A, Ström M. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment. Am J Gastroenterol 2009;104:679-85